Vascepa

Amarin's Vascepa Ends January With Flat Prescription Growth, But Still Trending Up
Seeking Alpha
Mon, 02/9/15 - 09:01 pm
Vascepa
Amarin
Amarin: Kowa Co-Promotion Agreement May Be Boosting Sales
Seeking Alpha
Mon, 01/5/15 - 10:12 am
Amgen
Kowa
Vascepa
Amarin Says It Will Complete Cardiovascular Outcomes Trial For Its Fish Oil Pill
Forbes
Tue, 09/16/14 - 02:32 pm
Amarin
fish oil
clinical trials
Vascepa
Third Time Was No Charm, FDA Denies Amarin Vascepa SPA Appeal
TheStreet.com
Fri, 09/12/14 - 10:38 am
FDA
Amarin
Vascepa
Amarin Scrapes The Bottom Of The Barrel
Seeking Alpha
Fri, 06/27/14 - 09:49 am
Amarin
Kowa
Vascepa
Amarin announces Vascepa case study publication
Yahoo/Fly on the Wall
Wed, 06/11/14 - 09:54 am
Amarin
Vascepa
Lovaza
Amarin triples size of Vascepa sales force with Kowa promo deal
Fierce Pharma
Wed, 04/2/14 - 09:53 pm
Kowa
hirings
Amarin
drug reps
Vascepa
Amarin: How The Co-Promotion Agreement With Kowa Affects Required Sales Targets
Seeking Alpha
Tue, 04/1/14 - 08:01 am
Amarin
Kowa
Vascepa
If You Can't Make Your Drug a Blockbuster, Sue Your Competitor
Motley Fool
Tue, 03/4/14 - 10:25 pm
Vascepa
Amarin
GSK
AstraZeneca
Amarin Sues FDA Over Exclusivity for Fish Oil Pill
Bloomberg
Fri, 02/28/14 - 08:26 am
Amarin
FDA
Vascepa
exclusivity
Two Years Less Exclusivity Is the Least of Amarin's Issues
Motley Fool
Tue, 02/25/14 - 11:15 am
Amarin
exclusivity
Vascepa
Amarin Loses Bid for Vascepa 5-Year Market Exclusivity
TheStreet.com
Mon, 02/24/14 - 08:51 am
Amarin
Vascepa
Amarin Tumbles after DMEP Decision
Yahoo/Zacks.com
Wed, 01/22/14 - 05:23 pm
Amarin
DMEP
Vascepa
Amarin says FDA won't reinstate special protocol assessment for ANCHOR study
First Word Pharma
Tue, 01/21/14 - 08:12 am
FDA
Amarin
Vascepa
Amarin says FDA delays decision on Vascepa trial design
Yahoo/Reuters
Thu, 01/16/14 - 06:50 am
FDA
Vascepa
clinical trials
Amarin Out, Intercept Pharma In at JPMorgan Healthcare Confab
TheStreet.com
Mon, 01/13/14 - 08:40 am
Amarin
Intercept Pharma
JPMHC 2014
OCA
Vascepa
Small Cap BioPharmas With Near-Term Catalysts
Seeking Alpha
Fri, 01/3/14 - 12:00 pm
Amarin
Venaxis
Progenics
Celldex Therapeutics
Relistor
Vascepa
4 Biggest Biotech Disasters Of 2013
Forbes
Wed, 01/1/14 - 11:41 am
Amarin
Vascepa
Ariad Pharmaceuticals
Iclusig
Celsion
ThermoDox
IPI-145
Infinity Pharmaceuticals
Amarin: 3 Things Shareholders Should Demand In 2014
Seeking Alpha
Mon, 12/30/13 - 11:12 am
Amarin
Vascepa
Is Amarin's Luck About to Change?
Motley Fool
Tue, 12/24/13 - 09:48 am
Amarin
Vascepa

Pages